(Press-News.org) DALLAS – June 24, 2011 – A new anti-inflammatory drug used by patients with type 2 diabetes improved their kidney function during a year-long study involving researchers from UT Southwestern Medical Center.
The study findings, reported in today's New England Journal of Medicine, mark the first time a drug therapy has led to improved kidney function for patients with type 2 diabetes and chronic kidney disease. Previous studies have identified drugs that slowed the deterioration of kidney function, said Dr. Robert Toto, director of the Houston J. and Florence A. Doswell Center for the Development of New Approaches for the Treatment of Hypertension at UT Southwestern.
"In diabetes, kidney function tends to deteriorate over time," Dr. Toto said. "No prior studies of this duration have shown what appears to be an increase in kidney function by any therapy, which makes this a very exciting development."
Type 2 is the most common form of diabetes, the leading cause of kidney failure in the U.S. Diabetics account for nearly half of all new cases of end-stage renal disease, the point at which patients require dialysis or a kidney transplant, said Dr. Toto, professor of internal medicine.
The study involved 227 adult patients with type 2 diabetes and chronic kidney disease. They were divided into four groups – three receiving different dosages of bardoxolone methyl, an anti-inflammatory drug, and the fourth group receiving a placebo and acting as a control.
The patients were tracked for 56 weeks, with measurements of their kidney function taken every four weeks. At study-highlighted weeks 24 and 52, researchers saw an overall significant increase in the estimated glomerular filtration rates, which are measurements of how well the kidneys are functioning, for the patients receiving the drug.
At 56 weeks, four weeks after researchers stopped administering the drug, a third measurement showed that patients continued to maintain a slightly higher level of kidney function compared to baseline measurements taken at the study's start.
"That is important because it implies the beneficial effect of the drug lasts for quite some time after it is discontinued," Dr. Toto said.
The most common side effects included muscle spasms, low blood magnesium levels and nausea.
The next step, Dr. Toto said, will be a longer-term clinical trial with a larger patient pool, necessary to confirm the effectiveness and safety of using the anti-inflammatory in people with type 2 diabetes and chronic kidney disease. He noted that it is important to interpret the current study's results cautiously, given the small number of patients and one-year duration of the study.
"The results of this study show promise for bardoxolone methyl in the treatment of kidney disease in those with type 2 diabetes," he said. "If it's confirmed to be effective and safe in the long term, this drug could potentially have a major positive impact on kidney disease and become part of the standard of care."
Dr. Philip Raskin, professor of internal medicine who leads the University Diabetes Treatment Center and the diabetes clinic at Parkland Memorial Hospital, also participated in the study, as did researchers at Reata Pharmaceuticals, Renal Associates in San Antonio, the University of Alabama-Birmingham, and Statistics Collaborative in Washington, D.C.
###
The study was funded by Reata, an Irving-based biopharmaceutical company founded in part by UT Southwestern faculty members.
This news release is available on our World Wide Web home page at
www.utsouthwestern.edu/home/news/index.html
To automatically receive news releases from UT Southwestern via email,
subscribe at www.utsouthwestern.edu/receivenews
Drug shows improved kidney function for type 2 diabetics, UT Southwestern researchers report
2011-06-25
ELSE PRESS RELEASES FROM THIS DATE:
Common drugs linked to cognitive impairment and possibly to increased risk of death
2011-06-25
INDIANAPOLIS – A large, long-term study confirms that medications with anticholinergic activity, which include many drugs frequently taken by older adults, cause cognitive impairment. The research is also the first to identify a possible link between these drugs – which include over-the-counter and prescription sleep aids and incontinence treatments – and risk of death.
The two-year study of the impact of these medications on 13,000 men and women aged 65 and older is part of the Medical Research Council (UK) Cognitive Function and Ageing Studies (CFAS), a large UK-based ...
Florida's Treacherous I-95, Setting for Multiple Car Accidents in May
2011-06-25
May was a popular month for auto accidents on Florida's I-95. Several car accidents took the lives of a handful of Florida drivers.
Northbound I-95 Car Accident Causes Explosion, Kills Taxi Cab Driver
Last month, a vehicle struck the rear end of a taxi cab while traveling northbound on I-95 in close proximity to 95th street causing both vehicles to catch on fire. The Florida Highway Patrol indicates that the vehicle struck the rear of the cab after the taxi blew a tire. The cab driver was pronounced dead at the scene. The driver of the other vehicle sustained minor ...
New genetic risk factors of lupus found in study of African-American women
2011-06-25
(Boston) - Researchers from Boston University's Slone Epidemiology Center have found four new genetic variants in the major histocompatibility complex (MHC) that confer a higher risk of systemic lupus erythemathosus ("lupus") in African American women. The study, which currently appears on-line in Human Genetics, is believed to be the first to comprehensively assess the association between genetic variants in the MHC region and risk of lupus in African American women.
The findings were based on the ongoing Black Women's Health Study, a prospective study of the health ...
Hidden lives of Baltimore's Irish immigrants unearthed for first time
2011-06-25
COLLEGE PARK, Md. - An archaeological team from the University of Maryland is unearthing a unique picture of the Baltimore-area's early Irish immigrants - of city children taught to read and write at home before widespread public education and child labor laws, as well as insular rural residents who resisted assimilation for one hundred years.
The excavation in the city represents the first formal archaeological research to focus on Baltimore's early Irish settlement and labor force.
"Behind the closed doors of their modest Baltimore homes, beyond the view of their ...
People With Disabilities Often Face Uphill Custody Battles
2011-06-25
The process of sorting out contested child-custody or visitation arrangements is almost always hard on families. And, individuals with disabilities commonly face additional challenges in these circumstances. The story of one California mother and her parents demonstrates these challenges as they fight to prove in court that even severely disabled parents have the right to see their children.
Fighting for Visitation
In 2006, Abbie Dorn was paralyzed following several medical errors during the process of giving birth to triplets. She was left unable to speak or move, ...
The mechanics of speciation
2011-06-25
Mate choice, competition, and the variety of resources available are the key factors influencing how a species evolves into separate species, according to a new mathematical model that integrates all three factors to reveal the dynamics at play in a process called sympatric speciation.
Titled "Factors influencing progress toward sympatric speciation," the paper appears in today's edition of the Journal of Evolutionary Biology.
New species more commonly occur when plants or animals cannot interbreed because of strong mate choice, and therefore they become isolated genetically. ...
Heart valve replacement without opening the chest gives new option for non-operable patients
2011-06-25
(CHICAGO) – An innovative approach for implanting a new aortic heart valve without open-heart surgery is being offered at Rush University Medical Center to patients with severe aortic stenosis who are at high-risk or not suitable candidates for open heart valve replacement surgery.
"This breakthrough technology could save the lives of thousands of patients with heart valve disease who have no other therapeutic options," says Dr. Ziyad Hijazi, director of the Rush Center for Congenital and Structural Heart Disease and interventional cardiologist of the Rush Valve Clinic. ...
200,000 patients treated for cardiac arrest annually in US hospitals, Penn study shows
2011-06-25
(PHILADELPHIA) -- More than 200,000 people are treated for cardiac arrest in United States hospitals each year, a rate that may be on the rise. The findings are reported online this week in Critical Care Medicine in a University of Pennsylvania Perelman School of Medicine-led study.
Though cardiac arrest is known to be a chief contributor to in-hospital deaths, no uniform reporting requirements exist across the nation, leaving experts previously unable to calculate its true incidence and study trends in cardiac arrest mortality and best practices in resuscitation care. ...
Invest in children's health, urges former US Surgeon General
2011-06-25
New Rochelle, NY, June 24, 2011—David Satcher, MD, PhD, former U.S. Surgeon General, describes childhood obesity as "one of the greatest threats to child and adult health that we are facing today," calling for an intensive effort to promote child health, in an editorial in the June issue of Childhood Obesity, a peer-reviewed journal published by Mary Ann Liebert, Inc. The editorial is available online.
A long-time advocate in the fight against obesity, Dr. Satcher released the first Surgeon General's Call to Action to Prevent and Decrease Overweight and Obesity during ...
Does Public Reporting of Medical Errors Increase Patient Safety or Lawsuits?
2011-06-25
KCRG TV reported that Iowa hospitals do not have to publically report medical errors. The question is how this influences patient safety in Iowa.
The hospitals claim that merely requiring reporting of medical errors to the state does not ensure that the errors will be corrected.
Scott McIntyre, spokesman for the Iowa Hospital Association, said to KCRG TV that, "Government regulation does not create that kind of buy-in or progress," and that "it can stifle innovation as providers focus on meeting the mandate and little more."
Minnesota's Experience
In ...